id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0199-0005,FDA,FDA-2004-E-0199,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-09-08T04:00:00Z,2006,9,,,2025-11-07T02:00:13Z,,0,0,0900006480470bc2
FDA-2004-E-0199-0004,FDA,FDA-2004-E-0199,Determination of Regulatory Review Period for Purposes of Patent Extension; XOLAIR,Notice,General Notice,2006-01-30T05:00:00Z,2006,1,2006-01-30T05:00:00Z,,2025-11-07T01:58:08Z,E6-1078,0,0,0900006480470bc0
FDA-2004-E-0199-0003,FDA,FDA-2004-E-0199,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-01-11T05:00:00Z,2006,1,,,2025-11-07T01:55:07Z,,0,0,0900006480470bbf